人工智能 (AI) 相關的聯盟和授權合約 (2016～2024年)

Artificial Intelligence (AI) Collaboration and Licensing Deals 2016-2024

出版日期: 2024年05月01日 | 出版商:

Current Partnering | 英文 500+ Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在本報告中，我們分析了人工智慧 (AI) 相關聯盟和授權協議的最新趨勢（2016-2024 年），包括交易總數的趨勢、財務方面的趨勢（支付條款），此外調查主要公司（共25家公司）的交易形成趨勢、合約條件的趨勢、技術的詳細趨勢等，並彙整近年來主要合作交易的詳細資訊。

簡介
人工智能相關的交易的長期趨勢
人工智能相關最活躍的交易業者
人工智能相關的交易:各交易類型
人工智能相關的交易:各治療領域
人工智能相關的交易:各業界
人工智能相關的交易:交易條件
- 人工智能相關的交易:交易總額
- 人工智能相關的交易:預付款金
- 人工智能相關的交易:階段性付款
- 人工智能相關的交易:權利金費率

第3章人工智能相關的主要交易

簡介
人工智能相關的主要交易:各金額

第4章人工智能相關最活躍的交易企業

簡介
人工智能相關的最活躍的交易企業
人工智能相關的最活躍的交易企業的簡介

第5章人工智能相關的契約締結一覽

簡介
人工智能相關的契約締結一覽

第6章人工智能相關的交易:各技術種類

交易一覽
交易一覽:人工智能相關，各企業 (ABC順序)
交易一覽:人工智能相關，各交易類型
交易一覽:人工智能相關，各治療領域
交易的種類定義
關於Biopharma Research Ltd
目前聯盟
目前契約
Current Partnering出版的最近報告標題

簡介目錄

Product Code: CP2125

Artificial Intelligence (AI) Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the artificial intelligence deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of artificial intelligence deals from 2016 to 2024.

The report provides a detailed understanding and analysis of how and why companies enter artificial intelligence deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 965 artificial intelligence deals announced since 2016 including financial terms where available including links to online deal records of actual artificial intelligence partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of artificial intelligence dealmaking.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in artificial intelligence dealmaking since 2016.

Chapter 3 provides an overview of the leading artificial intelligence deals since 2016. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in artificial intelligence dealmaking with a brief summary followed by a comprehensive listing of artificial intelligence deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of artificial intelligence deals signed and announced since Jan 2016, where a contract document is available in the public domain.

Chapter 6 provides a comprehensive and detailed review of artificial intelligence partnering deals signed and announced since Jan 2016. The chapter is organized by specific artificial intelligence technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in artificial intelligence deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Artificial Intelligence (AI) Collaboration and Licensing Deals provides the reader with the following key benefits:

Understand deal trends since 2016
Browse artificial intelligence collaboration and licensing deals
Benchmark analysis - identify market value of transactions
Financials terms - upfront, milestone, royalties
Directory of deals by company A-Z, deal type and therapy area
Leading deals by value
Most active dealmakers
Identify assets and deal terms for each transaction
Access contract documents - insights into deal structures
Due diligence - assess suitability of your proposed deal terms for partner companies
Save hundreds of hours of research time

Report scope

Artificial Intelligence (AI) Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of artificial intelligence trends and structure of deals entered into by leading biopharma companies worldwide.

Artificial Intelligence (AI) Collaboration and Licensing Deals includes:

Trends in artificial intelligence dealmaking in the biopharma industry
Directory of artificial intelligence deal records covering pharmaceutical and biotechnology
The leading artificial intelligence deals by value
Most active artificial intelligence licensing dealmakers
Artificial Intelligence (AI) Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in artificial intelligence dealmaking

2.1. Introduction
2.2. Artificial intelligence deals over the years
2.3. Most active artificial intelligence dealmakers
2.4. Artificial intelligence deals by deal type
2.5. Artificial intelligence deals by therapy area
2.6. Artificial intelligence deals by industry sector
2.7. Deal terms for artificial intelligence deals
- 2.7.1 Artificial intelligence deals headline values
- 2.7.2 Artificial intelligence deal upfront payments
- 2.7.3 Artificial intelligence deal milestone payments
- 2.7.4 Artificial intelligence royalty rates